Find out what’s new

Opportunistic screening with AI could be a game-changer for preventive cardiology

Non-Alcoholic Fatty Liver Disease, Heart Failure, and Long-Term Mortality: Insights From the National Health and Nutrition Examination Survey

To evaluate the association between non-alcoholic fatty liver disease (NAFLD), heart failure (HF), and all-cause mortality. Both NAFLD and HF are increasing in prevalence due to shared risk factors.

Use of AI opportunistic screening in CT for cardiovascular disease

“We’re finding that when you apply AI to these non-cardiac chest CTs, it’s possible to detect coronary calcifications in patients who may otherwise go unnoticed,” explained Ron Blankstein, MD

Forbes Article: AI In Healthcare: A New Era Of Personalized Patient Care

Nanox Highlighted on TIME’s Best Inventions of 2024 List for its AI Solutions

Nanox AI’s Solutions selected for Special Mention on annual list recognizing the most impactful new products and ideas

AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease

This new AASLD Guidance document reflects many advances in the field pertinent to any practitioner caring for patients with NAFLD and emphasizes advances in noninvasive risk stratification and therapeutics.

AI Empowering Early Detection of CAD Patients for Improved Cardiac Care

Findings presented at SCCT 2024

Optimizing Preventive Cardiology: Harnessing AI for Early Detection of Coronary Artery Disease

Findings presented at SCCT 2024

Artificial Intelligence in Medical Imaging: An Overview of a Decade of Experience

Medical imaging data has been at the frontier of artificial intelligence innovation in medicine with many clinical applications.

Evaluation Of The Diagnostic Potential Of A Novel Tomosynthesis System For MSK

Digital tomosynthesis (DTS) is a well-established technology that has become the gold standard for breast mammography. In recent years its benefits in musculoskeletal (MSK) imaging have been acknowledged and lead to a rapid increase in its utilization.

Evaluation Of The Diagnostic Potential Of A Novel Tomosynthesis System For Chest And Lung Diseases

Chest Digital Tomosynthesis (DTS) is known for its capability to overcome significant chest radiographs limitations (CXR). It improves detection of chest lesions and their anatomic localization and can exclude false lesions.